FibroGen Inc (NASDAQ:FGEN) traded at $1.12 at close of the session on Tuesday, April 30, made an upward move of 2.75% on its previous day’s price.
Looking at the stock we see that its previous close was $1.09 . In terms of its 52-week price range, FGEN has a high of $19.47 and a low of $0.33. The company’s stock has lost about -52.54% over that past 30 days.
FibroGen Inc has a market cap of $111.41 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.42, with the EPS growth for the year raised at -$1.33 for 2024 and -$0.44 for next year. These figures represent 54.50% and 66.90% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $36.67 million, with a low of $31.89 million and a high of $41.44 million. The median projection represents growth squeezing down to 15.20% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $155.41 million, or 5.20% up from figures reported last year.
On the other hand, looking at the outlook for the FGEN stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -15.80% off its SMA20 and -37.03% from its 50-day simple moving average. The RSI (14) is pointing at 34.70 while the volatility over the past week is 13.49% and jumps to 15.76% over the past one month. The beta value is 0.85, while the average true range (ATR) is currently pointing at 0.19.
Coming back to FibroGen Inc (NASDAQ:FGEN), we note that the average 3-month trading volume was 2.43 million. Current shares outstanding are 98.77 million.
The insiders hold 7.08% of the company’s shares while institutions hold 69.09%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 26.37% up in year-to-date price movement.
